Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HighLife™ Transcatheter Mitral Valve Replacement System for Severe Mitral Regurgitation in Patients at High Surgical Risk

NCT02974881 is registered in ClinicalTrials.gov with HighLife SAS as lead sponsor.

NCT NCT02974881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02974881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HighLife™ Transcatheter Mitral Valve Replacement System for Severe Mitral Regurgitation in Patients at High Surgical Risk
Lead sponsor
HighLife SAS
Phase
Not applicable
Overall status
Completed
Start date
July 20, 2017
Completion date
January 16, 2024
Enrollment
5 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

mitral valve insufficiency, mitral valve regurgitation